MaaT Pharma SA
EPA:MAAT.PA
Overview | Financials
Company Name | MaaT Pharma SA |
Symbol | MAAT.PA |
Currency | EUR |
Price | 7.24 |
Market Cap | 100,585,110 |
Dividend Yield | 0% |
52-week-range | 6 - 9.9 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Herve Affagard |
Website | https://www.maatpharma.com |
An error occurred while fetching data.
About MaaT Pharma SA
MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD